Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies and Vaccines
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • Multimedia
    • Sponsored Videos
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies and Vaccines
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • Multimedia
    • Sponsored Videos
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
Review

Hypertension guidelines: Treat patients, not numbers

Wesam Aleyadeh, MD, Erika Hutt-Centeno, MD, Haitham M. Ahmed, MD, MPH and Nishant P. Shah, MD
Cleveland Clinic Journal of Medicine January 2019, 86 (1) 47-56; DOI: https://doi.org/10.3949/ccjm.86a.18027
Wesam Aleyadeh
Ministry of Health, Amman, Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Hutt-Centeno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haitham M. Ahmed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nishant P. Shah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shahn2@ccf.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Hypertension guidelines January 2019 - March 01, 2019

ABSTRACT

The updated 2017 American College of Cardiology and American Heart Association (ACC/AHA) guidelines for managing hypertension advocate tighter blood pressure control than previous guidelines. This review summarizes the evidence behind the guidelines, discusses the risks and benefits of stricter blood pressure control, and provides our insights on blood pressure management in clinical practice.

  • Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
View Full Text

REFERENCES

  1. ↵
    1. Whelton PK,
    2. Carey RM,
    3. Aronow WS,
    4. et al
    . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006
    OpenUrlFREE Full Text
  2. ↵
    1. Chobanian AV,
    2. Bakris GL,
    3. Black HR,
    4. et al
    . The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19):2560–2572. doi:10.1001/jama.289.19.2560
    OpenUrlCrossRefPubMed
  3. ↵
    1. Go AS,
    2. Bauman MA,
    3. King SM,
    4. et al
    . An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension 2014; 63(4):878–885. doi:10.1161/HYP.0000000000000003
    OpenUrlCrossRefPubMed
  4. ↵
    1. James PA,
    2. Oparil S,
    3. Carter BL,
    4. et al
    . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311(5):507–520. doi:10.1001/jama.2013.284427
    OpenUrlCrossRefPubMed
  5. ↵
    1. Wright JT Jr.,
    2. Fine LJ,
    3. Lackland DT,
    4. Ogedegbe G,
    5. Dennison Himmelfarb CR
    . Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med 2014; 160(7):499–503. doi:10.7326/M13-2981
    OpenUrlCrossRefPubMed
  6. ↵
    1. Weber MA,
    2. Schiffrin EL,
    3. White WB,
    4. et al
    . Notice of duplicate publication [duplicate publication of Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 2014; 16(1):14–26. doi:10.1111/jch.12237] J Hypertens 2014; 32(1):3–15. doi:10.1097/HJH.0000000000000065
    OpenUrlCrossRefPubMed
  7. ↵
    1. Rosendorff C,
    2. Lackland DT,
    3. Allison M,
    4. et al
    . Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens 2015; 9(6):453–498. doi:10.1016/j.jash.2015.03.002
    OpenUrlCrossRefPubMed
  8. ↵
    1. de Boer IH,
    2. Bangalore S,
    3. Benetos A,
    4. et al
    . Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care 2017; 40(9):1273–1284. doi:10.2337/dci17-0026
    OpenUrlFREE Full Text
  9. ↵
    1. Qaseem A,
    2. Wilt TJ,
    3. Rich R,
    4. Humphrey LL,
    5. Frost J,
    6. Forciea MA
    . Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2017; 166(6):430–437. doi:10.7326/M16-1785
    OpenUrlCrossRefPubMed
  10. ↵
    1. The Trials of Hypertension Prevention Collaborative Research Group
    . Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in over-weight people with high normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med 1997; 157(6):657–667. pmid:9080920
    OpenUrlCrossRefPubMed
  11. ↵
    1. He J,
    2. Whelton PK,
    3. Appel LJ,
    4. Charleston J,
    5. Klag MJ
    . Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35(2):544–549. pmid:10679495
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Sacks FM,
    2. Svetkey LP,
    3. Vollmer WM,
    4. et al
    . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344(1):3–10. doi:10.1056/NEJM200101043440101
    OpenUrlCrossRefPubMed
  13. ↵
    1. Blackwell DL,
    2. Lucas JW,
    3. Clarke TC
    . Summary health statistics for US adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10; 2014(260):1–161. pmid:24819891
    OpenUrlPubMed
  14. ↵
    1. Muntner P,
    2. Carey RM,
    3. Gidding S,
    4. et al
    . Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. J Am Coll Cardiol 2018; 71(2):109–118. doi:10.1016/j.jacc.2017.10.073
    OpenUrlFREE Full Text
  15. ↵
    1. SPRINT Research Group
    2. Wright JT Jr.,
    3. Williamson JD,
    4. Whelton PK,
    5. et al
    . A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373(22):2103–2116. doi:10.1056/NEJMoa1511939
    OpenUrlCrossRefPubMed
  16. ↵
    1. Bress AP,
    2. Kramer H,
    3. Khatib R,
    4. et al
    . Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey). Circulation 2017; 135(17):1617–1628. doi:10.1161/CIRCULATIONAHA.116.025322
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Williamson JD,
    2. Supiano MA,
    3. Applegate WB,
    4. et al
    . Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomized clinical trial. JAMA 2016; 315:(24)2673–2682. doi:10.1001/jama.2016.7050
    OpenUrlCrossRefPubMed
  18. ↵
    1. Beddhu S,
    2. Rocco MV,
    3. Toto R,
    4. et al
    . Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial. Ann Intern Med 2017; 167(6):375–383. doi:10.7326/M16-2966
    OpenUrlCrossRefPubMed
  19. ↵
    1. Brunström M,
    2. Carlberg B
    . Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med 2018; 178(1):28–36. doi:10.1001/jamainternmed.2017.6015
    OpenUrlCrossRefPubMed
  20. ↵
    1. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
    . Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265(24):3255–3264. pmid:2046107
    OpenUrlCrossRefPubMed
  21. ↵
    1. Bulpitt CJ,
    2. Beckett NS,
    3. Cooke J,
    4. et al
    . Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21(12):2409–2417. doi:10.1097/01.hjh.0000084782.15238.a2
    OpenUrlCrossRefPubMed
  22. ↵
    1. Liu L,
    2. Zhang Y,
    3. Liu G,
    4. et al
    . The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005; 23(12):2157–2172. pmid:16269957
    OpenUrlCrossRefPubMed
  23. ↵
    1. JATOS Study Group
    . Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31(12):2115–2127. doi:10.1291/hypres.31.2115
    OpenUrlCrossRefPubMed
  24. ↵
    1. Ogihara T,
    2. Saruta T,
    3. Rakugi H,
    4. et al
    . Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010; 56(2):196–202. doi:10.1161/HYPERTENSIONAHA.109.146035
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Ettehad D,
    2. Emdin CA,
    3. Kiran A,
    4. et al
    . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387(10022):957–967. doi:10.1016/S0140-6736(15)01225-8
    OpenUrlCrossRefPubMed
  26. ↵
    1. Sleight P
    . The HOPE study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst 2000; 1(1):18–20. doi:10.3317/jraas.2000.002
    OpenUrlCrossRefPubMed
  27. ↵
    Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355(9200):253–259. pmid:10675071
    OpenUrlCrossRefPubMed
  28. ↵
    1. Yusuf S,
    2. Bosch J,
    3. Dagenais G,
    4. et al
    . Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016; 374(21):2021–2031. doi:10.1056/NEJMoa1600176
    OpenUrlCrossRefPubMed
  29. ↵
    1. Yusuf S,
    2. Lonn E,
    3. Pais P,
    4. et al
    . Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 2016; 374(21):2032–2043. doi:10.1056/NEJMoa1600177
    OpenUrlCrossRefPubMed
  30. ↵
    1. Lonn EM,
    2. Bosch J,
    3. López-Jaramillo P,
    4. et al
    . Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016; 374(21):2009–2020. doi:10.1056/NEJMoa1600175
    OpenUrlCrossRefPubMed
  31. ↵
    1. Bundy JD,
    2. Li C,
    3. Stuchlik P,
    4. et al
    . Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol 2017; 2(7):775–781. doi:10.1001/jamacardio.2017.1421
    OpenUrlCrossRefPubMed
  32. ↵
    1. Emdin CA,
    2. Rahimi K,
    3. Neal B,
    4. Callender T,
    5. Perkovic V,
    6. Patel A
    . Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA 2015; 313(6):603–615. doi:10.1001/jama.2014.18574
    OpenUrlCrossRefPubMed
  33. ↵
    1. ACCORD Study Group
    2. Cushman WC,
    3. Evans GW,
    4. Byington RP,
    5. et al
    . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362(17):1575–1585. doi:10.1056/NEJMoa1001286
    OpenUrlCrossRefPubMed
  34. ↵
    1. SPS3 Study Group
    2. Benavente OR,
    3. Coffey CS,
    4. Conwit R,
    5. et al
    . Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013; 382(9891):507–515. doi:10.1016/S0140-6736(13)60852-1
    OpenUrlCrossRefPubMed

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 86 (1)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypertension guidelines: Treat patients, not numbers
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Hypertension guidelines: Treat patients, not numbers
Wesam Aleyadeh, Erika Hutt-Centeno, Haitham M. Ahmed, Nishant P. Shah
Cleveland Clinic Journal of Medicine Jan 2019, 86 (1) 47-56; DOI: 10.3949/ccjm.86a.18027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hypertension guidelines: Treat patients, not numbers
Wesam Aleyadeh, Erika Hutt-Centeno, Haitham M. Ahmed, Nishant P. Shah
Cleveland Clinic Journal of Medicine Jan 2019, 86 (1) 47-56; DOI: 10.3949/ccjm.86a.18027
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • HOW THE GOALS EVOLVED
    • EVERYONE AGREES ON LIFESTYLE
    • HYPERTENSION BEGINS AT 130/80
    • SPRINT: INTENSIVE TREATMENT IS BENEFICIAL
    • JNC 8 VS SPRINT GOALS: WHAT’S THE EFFECT ON OUTCOMES?
    • OTHER TRIALS THAT INFLUENCED THE GUIDELINES
    • BLOOD PRESSURE ISN’T EVERYTHING
    • WHAT ABOUT PATIENTS WITH COMORBIDITIES?
    • TREAT PATIENTS, NOT NUMBERS
    • OUR APPROACH
    • MOVING FORWARD
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Hypertension guidelines January 2019
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Update on medical management of acute hip fracture
  • Vaccination in pregnancy: A call to all providers for help
  • Frequently asked questions about managing cancer pain: An update
Show more Review

Similar Articles

Subjects

  • Nephrology
  • Preventive Care
  • Women's Health
  • Men's Health
  • Geriatrics
  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire